www.fdanews.com/articles/123868-inspire-8217-s-dry-eye-treatment-fails-late-stage-study

Inspire’s Dry Eye Treatment Fails Late-Stage Study

January 21, 2010

Biotechnology company Inspire Pharmaceuticals Inc. said Thursday its drug candidate for dry eye disease failed to meet key treatment goals in a late-stage study.
SanLuisObispo